Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate

NCT07344220 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer

Interventions

DRUG: DZ-002 - 5 mg/kg, 6 mg/kg, or 7 mg/kg

Sponsor

Hoag Memorial Hospital Presbyterian

Collaborators

[object Object]